Telomolecular and UNeMed Sign License for Nanoparticle Use

 

UNeMed and Telomolecular Sign License for Nanoparticle Use

UNeMed and Telomolecular sign a licensing agreement that may lead to new nanotechnology based therapies for aging and age-related disease.

SACRAMENTO, CA (PRWEB) January 31, 2006 -- Telomolecular Corp., a biotechnology company, that develops biopharmaceutical therapies designed to treat aging and age-related disease, today announced the signing of a global licensing agreement with UNeMed, Omaha Nebraska, the licensing agent for the University of Nebraska Medical Center, a leading licensor of advanced medical and biomedical products and patents. Under the agreement, Telomolecular is granted the right to perform research and development, and commercialize technologies, that may lengthen chromosomal telomeres in living animals, based upon the University of Nebraska Medical Center’s proprietary poly (D,L-lactide-co-glycolide) (PLGA) biodegradable nanoparticles.

Telomolecular intends to use these licensing rights to develop new types of pharmaceutical products that are useful in the treatment of human aging and in the correction of certain age-related diseases, such as atherosclerosis, arteriosclerosis, liver cirrhosis, Progeria, and many other presently incurable degenerative disorders.

According to Mr. Matthew A. Sarad, Chief Executive Officer of Telomolecular, “PLGA biodegradable nanoparticles is a new and important gene therapy tool. Our company hopes, with this platform, to develop market appropriate technologies of social and historical significance. We look forward to growing the relationship between Telomolecular, UNeMed, and the University of Nebraska Medical Center, in exciting ways.”

"The nanoparticle formulation and material release technology is ideally suited for the therapeutic applications described by Telomolecular Corporation," said UNeMed's President, Dr.Thomas McDonald. "We look forward to continuing to foster a productive and growing relationship between the University of Nebraska Medical Center and Telomolecular in developing this as well as other technologies of mutual interest."

About PLGA Biogegradable Nanoparticles
PLGA biodegradable nanoparticles are an FDA approved gene therapy product that has been extensively investigated for sustained and targeted/localized delivery of different agents including plasmid DNA, proteins and peptides and low molecular weight compounds. Molecules much too large for traditional gene therapies can be encapsulated and delivered with PLGA. PLGA is non-toxic, does not illicit an immune response, and causes high transfection rates.

About UNeMed
UNeMed is a service-oriented corporation that functions as the interface between the University of Nebraska Medical Center (UNMC) and industry to promote UNMC technology development and economic development in Omaha. In cooperation with UNMC inventors and the Intellectual Property Office, UNeMed drives and facilitates the transfer of the technologies invented on campus into the marketplace. UNeMed Corporation was established in 1992 as a for-profit subsidiary of UNMC.

About Telomolecular
Telomolecular develops nanotechnologies capable of delivering large-molecule proteins across human cell membranes. The corporation's primary focus is on the delivery of therapeutic agents that lengthen and repair chromosomal telomeres in living animals. Successful therapies based on this tactic may offset, and potentially reverse, many devastating age-related diseases and perhaps address the symptoms and signs recognized as human aging.

Telomolecular Investor Relations
Matthew A. Sarad
(916) 410-8681

###

Press Contact: Matthew Sarad
Company Name: TELOMOLECULAR
Email: email protected from spam bots
Phone: 916-410-8681
Website: www.telomolecular.com

Cub Pharmacies Help Seniors with Medicare Education Program

Minnesota Cub Pharmacies Help Seniors with Medicare Education Program

 

ST. PAUL, Minn.--(BUSINESS WIRE)--Jan. 30, 2006--Several Cub Pharmacies in Minnesota will host My Medicare Matters(TM), a free, one-on-one educational program to help Medicare participants and their families understand the new Medicare Prescription Drug Coverage. Forty-two million seniors in the U.S. face critical Medicare Part D choices that must be made by May 15, 2006.

The National Council on the Aging (NCOA) and the Access to Benefits Coalition (ABC) have recently launched My Medicare Matters nationwide in an effort to provide much needed impartial educational support for seniors at local events and community centers via computer equipped vans and expertly trained educators. The program is supported by The Minnesota Senior Federation, the primary grassroots organization of seniors in Minnesota. With more than 20,000 members and 100 affiliated organizations, the Federation is dedicated to helping seniors develop leadership skills and work toward positive social change locally, statewide and throughout the nation.

The My Medicare Matters team of educators will meet with individuals, family members and/or caregivers for 10 minutes ... 45 minutes ... or more until each senior's questions and concerns have been addressed.

At the events, seniors can sit down with benefits educators who will provide private, personalized guidance as they learn about the new coverage and their options. The educators will use the latest technology via Web-enabled computers, and use Internet-based tools during counseling sessions to help seniors compare plans and make the enrollment decision that is right for their health and their financial situation.

If and when seniors are ready to join a plan, the My Medicare Matters (TM) educators will also assist them in completing the online enrollment process or advise them about other methods for joining a plan.

My Medicare Matters sessions will be held according to the following schedule. Sessions at each location are always held from 1:00 p.m. to 4:00 p.m.:

-- Thursday, Feb. 2, 2006, Cub Foods, 7555 W. Broadway Ave., Brooklyn Park;

-- Friday, Feb. 3, 2006, Cub Foods, 250 33rd Ave. So., St. Cloud;

-- Wednesday, Mar. 1, 2006, Cub Foods, 2859 26th Ave. So., Minneapolis;

-- Friday, Mar. 3, Cub Foods, 2001 So. Robert St., West St. Paul;

-- Tuesday, Mar. 14, Cub Foods, 15350 Cedar Ave.; Apple Valley;

-- Monday, Mar. 27, Cub Foods, 2197 Old Hudson Rd., St. Paul;

-- Thursday, Mar. 30, Cub Foods, 1440 University Ave., St. Paul;

-- Wednesday, Apr. 5, Cub Foods, 8690 E. Point Douglas Rd., Cottage Grove;

-- Wednesday, April 12, Cub Foods, 701 W. Broadway Ave., Minneapolis;

-- Friday, Apr. 21, Cub Foods, 5397 Nicollet Ave., Minneapolis;

-- Tuesday, Apr. 25, Cub Foods, 7435 179th St., Lakeville;

-- Tuesday, May 2, Cub Foods, 1729 Market Blvd., Hastings;

-- Wednesday, May 10, Cub Foods, 4801 Hwy. 101, Minnetonka;

-- Monday, May 15, Cub Foods, 1059 Meadowlands Dr., White Bear Lake.

The Web site, www.MyMedicareMatters.org, is available for use by Medicare participants, and their families, friends, caregivers, professionals and organizations. The Web site provides educational materials, and Internet tools that can be used to learn about Medicare Part D, and links them to CMS' Medicare Prescription Drug Plan Finder. People who visit www.MyMedicareMatters.org will also be able to enroll online or request extra help from the Social Security Administration.

Nationally, My Medicare Matters has deployed a fleet of 37 mobile education vans that are bringing trained staff and technology to 27 states and the District of Columbia to offer help in 44 metro areas and nearly 300 counties across the country. My Medicare Matters intends to hold informational events in the Twin Cities throughout the Medicare Part D enrollment period which ends on May 15, 2006.

My Medicare Matters is being supported by AstraZeneca Pharmaceuticals LP, fulfilling the company's mission to improve patient health for seniors across the country. "We believe the Medicare Prescription Drug Benefit can make a tremendous contribution to the quality of life for millions of Americans and we commend the NCOA and the ABC for offering this crucial educational program for seniors," said Tony Zook, President and CEO designate.

Additional My Medicare Matters sessions are being scheduled at Cub Pharmacies. Consumers interested in attending should call their local Cub Pharmacy for a schedule of events. Consumers also may contact the Senior Linkage Line at 1-800-333-2433.

Contacts

My Medicare Matters(TM)
Katie Keller, 651-351-7032
or
SUPERVALU/Cub Foods
John Anderson, 612-455-1756

New Trial of Anticancer Drug From Genta

Genta Initiates New Trial of Anticancer Drug
Jan 29, 2006 11:22 AM

Genta Incorporated has entered the first patient into a new clinical study that will evaluate the bioactivity and safety of the company's lead anticancer drug, Genasense Injection, administered by intermittent subcutaneous injection.

The study employs a new formulation of Genasense that is five-fold more concentrated than material currently used in clinical trials. Having completed requisite animal toxicology work, the trial is proceeding pursuant to a separate investigational new drug application that was filed with the FDA.

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced cell death. By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment.

A prolonged subcutaneous infusion method using the existing intravenous formulation of the drug has been studied in patients with advanced non-Hodgkin's lymphoma. In this study the drug showed anti-tumor activity as a single agent and documented down-regulation of Bcl-2.

The new program seeks to extend these initial observations in a formal dose-ranging trial using the new, highly concentrated formulation.

"Genasense has demonstrated synergy with various treatments, such as Tarceva, interferon and radiation, all of which require multi-day schedules," commented Dr Raymond Warrell, Genta's chairman and CEO. "The new method may substantially increase patient convenience and expand the utility of Genasense, particularly in front-line and adjuvant settings."

Other resource sites:
Mesothelioma Lung Cancer
Mesothelioma Search Engine

Unfair Asbestos Legislation

 

Brayton Purcell Fighting Against Unfair Asbestos Legislation

Four clients of the Brayton Purcell law firm will travel to the capitol to fight against proposed asbestos legislation (S. 852). Three have developed cancers due to asbestos exposure; the fourth is a widow whose husband died from asbestos-related cancer.

Washington, DC (PRWEB)January 27, 2006 -- Four clients of the Brayton Purcell law firm will travel to our nation’s capitol next week to make their voices heard against S. 852. This unfair asbestos legislation would deny access to the courts for asbestos victims, who instead would be required to pursue their claims through an asbestos trust fund. Congressional analysts and other government experts predict that the trust fund would run out of money well before all asbestos victims could be compensated. Medical experts question the criteria that the bill uses to identify and classify the diseases related to asbestos.

A Father Suffering From Mesothelioma

One client, David Bakkie, was exposed to asbestos when he worked as an assembler, a lineman and a line construction supervisor. He is 50 years old and has two teenage sons, Christopher and Charles.

Last September, Mr. Bakkie was diagnosed with mesothelioma, an aggressive cancer that first attacks the membranes surrounding the lungs. The disease is caused by asbestos exposure.

A Ship Rigger’s Exposure to Asbestos

Ron Dutton is married and 51 years old. He has two daughters and a granddaughter. For many years, Mr. Dutton worked as a rigger on ships, a job that exposed him to asbestos. Like most other workers, he did not know about the danger to his health and was given no protection. Now he has asbestos–related colon cancer and asbestosis. Asbestosis is a progressive scarring of the lungs that is only caused by exposure to asbestos.

Mr. Dutton says that he is going to Washington to let the Senators know that workers who were exposed to asbestos have real illnesses and have the right to be compensated. He poses this question: “The government didn’t get in the way when asbestos manufacturers made huge profits, so why should it make it hard for people like me to be compensated when they become sick from asbestos products?”

An Asbestos Victim’s Widow

Joan Nettler Kiss became a widow last year when her husband, John, died of metastatic colon cancer. An insulator for 35 years, John Kiss was an active member of the Heat and Frost Insulators and Asbestos Workers Local 16 in San Francisco. He had worked in power plants, shipyards, and industrial and commercial sites throughout Northern California. He contracted asbestosis and colon cancer due to his exposure to asbestos at these jobs

After he retired as an insulator, Mr. Kiss began a second career as an investigator at Brayton Purcell because he wanted to help other asbestos victims. He was very proud of this job. His co–workers came to rely on his extensive knowledge of asbestos products and his ability to put clients at ease. Mr. Kiss eventually became the manager of the firm’s Investigations Department.

John Kiss had three children of his own and also helped raise two of Joan’s children. He was a proud grandfather to his eight grandchildren. He is sorely missed by his family, friends and co–workers.

A Machinist With Asbestos Lung Cancer

Mr. George Goodyard is married with four daughters. For 34 years, he worked as a machinist in naval and private shipyards. He now has asbestosis and lung cancer as the result of his on–the–job exposure to asbestos. He has had part of his lung removed, and visits his doctor every three months for a check–up and X–rays. He receives a CAT scan every six months, and hopes that his condition does not deteriorate further.

“They knew about asbestos in 1970, but didn’t tell us anything about it,” Mr. Goodyard said. “We didn't know about the risks we were taking.” He also points out that even today, the insulation used in ships may be 30 to 40 years old and contain asbestos. The asbestos can be easily disturbed and become airborne, allowing workers to breathe in asbestos fibers.

Mr. Goodyard has a court date set for later this year. However, if S. 852 becomes law, his asbestos case could be thrown out, and he would have to apply to the asbestos trust fund program instead. The delay would be a hardship for Mr. Goodyard and his family. The asbestos trust fund will not be up and running immediately, and S. 852 creates an unwieldy bureaucracy that may not be efficient or effective.

Protest Against S. 852

S. 852 is extremely bad legislation that will help asbestos–related companies, but harm people with asbestos diseases. Please call or write to your Senators and urge them to vote NO on S. 852. The bill may come before the Senate in early February, so it is important to do this right away. You can find your Senators’ names, e–mails, and telephone numbers on the U.S. Senate web site at http://www.senate.gov/general/contact_information/senators_cfm.cfm

List of Client Cases

The four clients are involved in these cases:
David Bakkie: David Bakkie vs. Asbestos Defendants, San Francisco Superior Court, No.     491129
Ron Dutton: Ronald Dutton and Terri Dutton vs. Asbestos Defendants, San Francisco Superior Court, No. 420971
Joan Nettler: Joan Nettler, et al vs. Asbestos Defendants, San Francisco Superior Court, No. 413663
George Goodyard: George Goodyard vs. Asbestos Defendants, San Francisco Superior Court, No. 434978

About Brayton Purcell
For over 20 years, Brayton Purcell has helped clients protect their legal rights in the face of devastating losses such as illness, injuries, and harm to family members. The law firm enjoys a national reputation for the high quality of its personal injury and product liability work, particularly in the area of asbestos litigation. For more information, call 415-898-1555 or visit the firm web site at http://www.braytonlaw.com.

For information about asbestos and asbestos-related diseases, see the firm’s web sites, Mesothelioma Network, http://www.mesotheliomasite.com and Asbestos Network, http://www.asbestosnetwork.com.

# # #

Press Contact: Butch LeRoy
Company Name: Brayton Purcell
Email: email protected from spam bots
Phone: 415 898-1555
Website: http://www.braytonlaw.com

---

[Editor's comments: For information on asbestos and the lung cancer called Mesothelioma that exposure to asbestos causes, please visit http://www.mesothelioma-lung-cancer.org. (hris ]

 

Safe Handling of Hazardous Drugs

 

“Safe Handling of Hazardous Drugs” Technical Paper from Baxa Corporation Now Posted on PublicRelationsNewsroom.com For Media Access Discussions from a scientific advisory board on the impact of USP 797 and the NIOSH Alert for guiding the safe handling of hazardous drugs in healthcare settings are the topics of a new technical paper posted at the Public Relations Newsroom Web site. This posting joins a related page at the Expert Information for Journalists Web site (Expert411.com) featuring James Jorgenson, RPh, MS, and Martha Polovich, MN, RN, AOCN, industry experts on the subject of safe handling. Denver, CO, December 22, 2005 --(PR.COM)-- With hazardous drug handling brought to the forefront of public scrutiny by USP 797 and the recent NIOSH Alert, a new technical paper has been posted at http://www.PublicRelationsNewsroom.com for media access. Baxa Corporation manufactures devices and systems for safe handling. packaging and distributing fluid medications. The new safe handling technical paper is found at: http://publicrelationsnewsroom.com/_wsn/page13.html The “safe handling of hazardous drugs” expert information page is found at http://www.expert411.com/_wsn/page9.html. The Journal of Community Oncology article featuring Marty Polovich and detailing hazardous drug handling risks is found at: http://www.communityoncology.net/journal/articles/0203277.pdf The NIOSH Alert, "Preventing Occupational Exposures to Antineoplastic and other Hazardous Drugs in Healthcare Settings," reflects years of work by physician, nurse, pharmacist and scientific experts in collaboration with members of the broad-based NIOSH Hazardous Drug Safe Handling working group. Among the findings in the Alert are warnings that previous workplace precautions for containing hazardous drugs have been inadequate. Examples include: * "Sessink and Bos noted that 11 of 12 studies detected cyclophosphamide in the urine of healthcare workers tested, indicating continued exposure despite safety precautions." (page 17) * "Considering all the data, the weight of the evidence in occupationally exposed cohorts demonstrates an association between exposures to hazardous drugs and increases in various measures of genotoxicity..." (page 19) * "Recent evidence summarized in this Alert documents that worker exposure to hazardous drugs is a persistent problem. Although most air sampling studies have not demonstrated significant airborne concentrations of these drugs, the methodology employed in the past has come into question...and may not be a good indicator of environmental contamination of the workplace. All studies that examined surface wipe samples have determined that surface contamination of the workplace is common and widespread." (page 41) The Alert recommends that employers improve environmental and employee protection where hazardous drugs are handled. The specific benefits of closed systems were called out: * "An investigation conducted in the US demonstrated a reduction in both the percentage of urine samples with measurable levels of cyclophosphamide or ifosfamide present and the concentration of the drugs in the urine following use of a closed-system device for six months..." (page 18) * "Transfers from primary packaging such as vials to dosing equipment (i.e., infusion bags, bottles or pumps) should be carried out using closed systems whenever possible. Devices that contain the product within a closed system during drug transfers limit the potential for aerosol generation, as well as exposure to sharps." (page 35) A leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa Corporation manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom and Denmark, and distribution partners worldwide. Further information is available at http://www.baxa.com. Click the following link to view a presentation by Jim Jorgenson, "Using a Closed System Device to Reduce Occupational Exposure to Hazardous Drugs." Jorgenson is Director of Pharmacy for the Huntsman Cancer Institute and Associate Dean for Professional Affairs at the University of Utah: http://www.isips.org/presentations/PhaSeal/player.html ### Contacts: Marian Robinson, Vice President, Marketing Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157 Email: marian.robinson@baxa.com Maggie Chamberlin Holben, APR Absolutely Public Relations 303.984.9801, 303.669.3558 Email: maggie@absolutelypr.com

Contact Information

Baxa Corporation Maggie Chamberlin Holben, APR 303.984.9801 or 303.669.3558 maggie@absolutelypr.com http://www.baxa.com

New State Health Insurance Laws and Regulations Directory

Gor a Health Insurance Beef or Question? New State Health Insurance Laws and Regulations Directory Can Help

Press Release by: Benefits Boutique

Published on openPR 01-20-2006 09:03 am - CET

(openPR) - Plano, Texas USA
Directory of State Health Insurance Laws Helps Answer Health Insurance Complaints and Questions

Where can you go when you have a health insurance question or complaint? Are you overwhelmed by conflicting health insurance advice from friends, relatives, or agents?

Today, www.BenefitsBoutique.com announces the introduction of the National Directory of State Health Insurance Laws and Regulations. Benefits Boutique is a nationwide insurance agency and advisory resource offering affordable health and life insurance and sound advice to individuals, families and the self-employed.

The Directory is a new, free resource for anyone shopping for or puzzled by health insurance. The Directory refers visitors to many governmental and private resources that can give objective answers to health insurance questions and lodge complaints with government officials for their state.

Consumers are encouraged to visit the new National Directory of State Insurance Laws and Regulations at: http://www.BenefitsBoutique.com/health%20insurance%20regulations . Directory links and news items are updated regularly, and visitors are encouraged to bookmark and add the Directory to their web browser favorites folder.

According to Michael Chapman, president of www.BenefitsBoutique.com, "We developed the National Directory of State Health Insurance Regulations as a public service for consumers. We found that important and accurate health insurance official information is not readily available in yellow pages or online directories. Too often people rely on biased or inaccurate information and advice from friends and relatives. And health insurance regulations and laws are constantly changing, so we have included the latest state news items as well."

Included in the directory are many links to state and federal insurance regulating agencies, including state departments of insurance. These regulatory agencies provide valuable public information about the health insurance laws and regulations of their state, such as the complaint levels for health and life insurance companies and of licensed agents in the state.

Government-compiled complaint ratings are one important and objective measurement of quality and customer satisfaction which should be part of the consideration of individuals, families or the self-employed when shopping for affordable health insurance. Many state departments of insurance also offer a toll-free hotline service for individuals seeking sound health insurance advice, or who desire to file a complaint against their insurance company or agent.

Benefits Boutique offers nationwide, no-obligation, affordable health and life insurance quotes, sound advice and personal service. Consumers can visit the company website, www.BenefitsBoutique.com or call toll-free for answers to health and life insurance questions and no-obligation quotes. Consumers can even schedule a no-obligation consultation with a health insurance advisor from Benefits Boutique via a toll-free number, a free video web-conference or through Skype, a company owned by eBay.com that provides free online phone service around the world.

Contact Michael Chapman for more insights into this topic. Direct line: (888) 398-6246 Email: mtchapman@BenefitsBoutique.com Other helpful information regarding the can be found at: http://www.BenfitsBoutique.com.

For More Information Contact:

Michael Chapman
mtchapman@BenefitsBoutique.com
http://www.BenefitsBoutique.com
(888) 398-6246

Treatment Options Enhanced for Pediatric Oncology Patients

 

FLAVORx Enhances Treatment Options for Pediatric Oncology Patients

Because of the struggles that young cancer patients face on a day to day basis during and after treatment, FLAVORx is dedicated to defining methods in which they can best accommodate their needs to make their situation that much more bearable. Working with several cancer-related medications and consumer responses, FLAVORx has discovered flavorings that improve several cancer medications' taste most effectively, and therefore improves patient quality of life.

Bethesda, MD (PRWEB) January 19, 2006 -- It is estimated that approximately 12,400 children in the United States are diagnosed with cancer each year. The most common childhood cancers are leukemia, lymphomas, brain tumors and bone cancers. The frequency of cancer diagnoses has risen since the 1970’s. In each individual case, cancer patients and their families must endure the pain, uncertainty and disruptions caused to their lives as a result of the diagnosis. Recognition of the needs of these pediatric oncology patients and the opportunity to improve the quality of their lives has led FLAVORx to dedicate a targeted investigation on how they can best serve the needs of childhood cancer patients.

The chemotherapy, doctor’s exams, constant discomfort of their condition and the countless medications these children must tolerate, is more than even the strongest adult could endure. Beyond the physical and medical changes to a child’s lifestyle, diagnosis and treatment also cause feelings of fear, anxiety, anger, guilt, sadness and depression. Therefore, any way of making these children’s lives a little easier, a little less painful and a little less traumatic is what FLAVORx strives for. Succeeding in this manner is what sets FLAVORx apart as a company dedicated to understanding the needs and situations of all children.

Medications used during cancer treatment are essential to alleviate or eradicate the signs of cancer from the body and can be classified into two groups: antineoplastic (cancer-fighting) or immuno-suppression (lessening the body’s reaction). These include drugs that can prevent infection, like antibiotics, or drugs that treat side effects such as nausea and pain. FLAVORx testing and research with children has shown that some flavors mask the existing tastes of certain medications better than others. Of the following common cancer medications, here are some of the most effective flavors:

1. Zofran (for nausea associated with chemotherapy)- Raspberry, Natural Orange, Bubblegum
2. Phenergan (for nausea associated with chemotherapy)- Grape, Sour Apple, Peaches and Cream
3. Acyclovir (to prevent viral infections)- Orange Cream, Banana, Cherry
4. Septra/Bactrim (to prevent some types of pneumonia)- Grape, Bubblegum, Watermelon
5. Vancomycin (an antibiotic)- Vanilla, Strawberry Cream, Grape/Bubblegum
6. Roxanol (to relieve pain)- Grape, Raspberry, Orange Cream

Because FLAVORx flavors are inert, non-allergenic, sugar-free, alcohol-free, very concentrated, as well as gluten and casein-free, they do not affect the efficacy of the medication and also comply with any specific dietary restraints (to reduce the risk of infection from food) that many oncology patients must follow.

Many years ago, a father came to FLAVORx with a problem. His young son had an inoperable brain tumor and was on a very strict regimen of medications. In anticipation of the medications’ taste, the young boy would become nauseated hours before he had to take them everyday, and simply could not keep them down. With no foreseeable solution, his parents were told if he couldn't ingest the medications necessary for his survival, they would have no choice but to return him to the hospital and administer the medications intravenously. Needlessly readmitting their son to the hospital would add unnecessary strain and suffering to an already unbearable situation. The family knew he would only be comfortable in a home setting, not in a cold, sterile hospital. They finally found FLAVORx and Kenny asked the entire family to come in to see how he could help. Kenny asked the little boy to name his favorite flavor, and without hesitation, he responded “Reese’s Peanut Butter Cups.” Kenny created a formulation using a combination of peanut butter and chocolate flavoring to pair with each of his medications.After that the young boy was able to take all of his medicine without opposition. Sadly, he only lived for eight more months but his final months were spent at home with his family and those that loved him, surrounded by familiarity. Kenny recalls, “Knowing that we were able to bring this child a little happiness at the end of his life is a feeling that I will never forget. It was a feeling of triumph over an otherwise cold world that for the most part didn’t do all it could to help a little boy, and value the importance of his life. I will always remember him and feel we succeeded by helping him and his family. After this, I vowed I would never let another child’s health and happiness fall by the wayside if I could help it.”

It is extremely important that children with compromised immunity, as in the case of cancer, take all medications prescribed by their physicians as they are precisely directed. FLAVORx has improved treatment quality in administering medicines by alleviating the unnecessary strain, trauma and more importantly, ramifications of medicinal non-compliance by improving the taste of unpalatable medications. FLAVORx President and CEO, Kenny Kramm, has brought increased pediatric oncology awareness to his company, as well as a heightened dedication to patient needs. FLAVORx offers 42 scientifically developed and safety-tested flavors to cover both over-the-counter and prescription medications and is available at most pharmacies nationwide.

For more information, please contact Teresa Chen at 800.884.5771, extension 234.

# # #

Press Contact: Teresa Chen
Company Name: FLAVORX, INC.
Email: email protected from spam bots
Phone: 240.223.0953
Website: www.flavorx.com

Carmel Pharma to Market and Distribute Clinically-Proven Closed System Transfer Device

 

Carmel Pharma, Inc. to Market and Distribute PhaSeal®, the Only Clinically-Proven Closed System Transfer Device Available Today

At the beginning of 2006, Carmel Pharma, Inc. applies its passion and undivided resources to the distribution and education of their own product, PhaSeal®--the only "clinically-proven" closed system transfer device available today. PhaSeal's unique design "contains the drug" which helps prevent occupational exposure to hazardous drugs in health care settings--a call to action required by The National Institute for Occupational Safety.

Columbus, OH (PRWEB) January 18, 2006 -- Carmel Pharma began to market and distribute PhaSeal® from its own company, Carmel Pharma Inc, based in Columbus Ohio as of January 2006.

PhaSeal is the only "clinically proven" closed system transfer device on the market today. It's unique design is meant to prevent environmental contamination and help protect healthcare employees through the preparation, administration and waste handling of hazardous drugs.

The National Institute for Occupational Safety (NIOSH) states that "working with or near hazardous drugs in health care settings may cause skin rashes, infertility, miscarriage, birth defects, and possibly leukemia or other cancers," quotes David Schneider, President of Carmel Pharma Inc. "The PhaSeal System contains the hazardous drug which prevents enviromental contamination, therefore providing healthcare workers a safer working environment. As the manufacturer, our sole focus is to continue to educate and be a valuable resource on this important safety issue."

PhaSeal's double membrane provides dry connections between system components and it's expansion chamber ensures aerosols and vapors are contained and neither over pressure or under-pressure occurs duing drug preparation.

PhaSeal was launched in the US in December of 2000 and today, more than 400 leading cancer facilities, such as MD Anderson, University of San Francisco, Standford and Texas Childrens Hospital have contributed to PhaSeal's outstanding growth. Carmel Pharma has recently been placed on the Deloitte´s Fast 500 EMEA List.

If you have questions or want more information on ordering PhaSeal, please contact Carmel Pharma, Inc. at
866-487-9250 or 614-841-0504.

Contacts:
Christine Crooks, Marketing Director Carmel Pharma, Inc.
Direct: 866-487-9250 ext. 202

Agneta Ekblad, VP Oncology Solutions Carmel Pharma Inc. Direct: 858-220-3583

David Schneider, President Carmel Pharma Inc.
Direct: 866-487-9250 ext. 201

# # #

Press Contact: Christine Crooks
Company Name: CARMEL PHARMA, INC.
Email: email protected from spam bots
Phone: 614-841-0504
Website: www.phaseal.com

Breast Cancer Wristbands Contribute To A Growing Trend

Press Release by: jennyandrews

Published on openPR 01-17-2006 09:00 am - CET

(openPR) - As the trend of breast cancer wristbands grows, a plethora of other wristband charities compete for a piece of the pie.

The original awareness wristband, known as the “Livestrong” wristband, was designed by the Lance Armstrong Foundation and was bright yellow to match the cyclist’s uniform. Lance Armstrong is most widely known for beating testicular cancer and winning the Tour de France. In an attempt to educate people on cancer and raise money for research and development, the silicone bracelets were an innovative way to get people’s attention. However, it may have worked too well. After the bracelets were featured on Oprah, they became even more popular. Soon they were being mimicked by every charity and awareness group imaginable in every possible color. It began with breast cancer awareness and grew from there. Now, you can find bracelets raising money for Tsunami victims, Katrina victims, and even on seatbelt safety awareness.

For this reason, a great deal of controversy is growing over the wristbands. Many, included Timothy Noah, Slate journalist, have contended the bracelets are little more than a fashion trend at this point and have lost their original meaning. With the multitude of colors and designs, there is almost no way to tell what charity someone is trying to support, not to mention the narcissistic idea of wanting to advertise charitable contributions in the first place. See http://www.breastcancerwristbands2.com/articles/breast-cancer-wristbands.html for more information.

Another issue comes to play when third parties sell these awareness bracelets. Often, when this happens, only a small portion of the proceeds actually goes to the intended charities. There are also several scams that sell knock-off bracelets for no charitable purpose. An effort is being made to educate people on the existence of these situations in which they may be taken for granted.

For more information go to http://www.breastcancerwristbands2.com/articles/breast-cancer-wristbands.html

Genetic Testing In The Convenience Of Your Own Home

 

Scientific Advances In The Field Of Nutrigenomics Target The Future of Disease Prevention; Customized Nutrition & Lifestyle Programs Formulated Through Genetic Testing

Genetic testing and the Nutriceutical Industry have joined forces in the pursuit of optimizing our ability to look into the future to foresee disease before it happens. The goal: to customize individual nutritional supplementation & lifestyle programs based on individual genetic “weaknesses” or "variances" that leave individuals more prone to certain diseases.

(PRWEB) January 13, 2006 -- Genetic testing and the Nutriceutical Industry have joined forces in the pursuit of optimizing our ability to look into the future to foresee disease before it happens. The goal: to customize individual nutritional supplementation & lifestyle programs based on individual genetic “weaknesses” or "variances" that leave individuals more prone to certain diseases. Many publications have highlighted the possibility of being able to identify the unique nutritional needs of an individual through genetic testing, "some time in the future". That future is now.

A Genetic/DNA Screening Analysis Kit and Personalized Analysis Report now make this healthful resource available to anyone, anytime, affordably … in the convenience of your own home. Families across America can use convenient Testing Kit products to reveal important lifestyle, nutritional, health related, and preventive analysis data within a few short weeks. This diagnostic breakthrough provides an excellent resource for those searching for answers to critical health questions.

Everyone has “unique genetic make-up”, and thus, “unique genetic weaknesses”, and unique nutritional needs. In the past, many leading medical researchers and doctors, summarized the application of nutritional supplementation as no more than the creation of expensive urine. Current research and application shows the efficacy of dietary supplementation of vitamins, minerals & and more targeted nutritional products on overall health and prevention of disease.

“Nutrigenomics” is the cutting edge science linking nutrients & other dietary bioactives (toxins, chemicals, etc) with the genetic variances. Even a slight variation in a gene or "genetic letter" can totally alter the genetic message, like changing one letter in a word can completely alter the meaning, like "deer" to "beer". Slight changes in these genetic codes can completely alter physiologic processes, and thus life-health issues. If these genetic code alterations are determined, addressing disease prevention with nutritional programs and lifestyle choices becomes “the epitome of prevention” for long-lasting, optimum health.

Knowing one’s critical genetic make-up provides the future for health related issues and prevention. Convenient, Genetic Testing provides a comprehensive preventive road map identifying variances related to Heart Health, Bone Health, Antioxidant & Detoxification Capacity, Inflammation Response, and Insulin Sensitivity. Combined with personalized Weight Management systems should the need exist, millions of Americans can enjoy a brighter future, and elevated quality of life.

Nutrigenomics is a boundless field of discovery that can be used to the human advantage. Americans can tap into this potential as an important personal resource for themselves and their families. Testing process is affordable, confidential, rapid, and results oriented. Change your life today.

For more information contact: Maureen Maples, DC, FASA www.DrMaples.ws

Dr. Maples has been helping patients fight disease and achieve their wellness & weight management goals for almost 10 years through various alternative healthcare methods.

###

Press Contact: Maureen Maples
Company Name:
Email: email protected from spam bots
Phone: 704-654-9560
Website: http://www.drmaples.ws

Proposed Asbestos Legislation Analyzed from a Historical Perspective

 

Mesothelioma.com Analyzes Proposed Asbestos Legislation from a Historical Perspective

Bill s.852, the Fairness in Asbestos Injury Resolution Act of 2005, is analyzed according to historical precedent.

(PRWEB) January 12, 2006 -- Mesothelioma.com today announced further opposition to the bill S.852 - the Fairness in Asbestos Injury Resolution Act of 2005. The bill is expected to receive intense scrutiny in the coming weeks, as it could be voted on this month or in the month of February. Mesothelioma.com was one of the first to criticize the bill on grounds that it is unfair to victims of this horrible affliction, especially United States veterans.

In recent weeks, Mesothelioma.com staffers have performed unbiased historical research and data mining using similar programs as models, uncovering some startling findings. Around the same time the United States Government Accountability Office ("GAO") reviewed four federal compensation programs designed to compensate individuals injured due to exposure to harmful substances- black lung, vaccine injury, radiation exposure, energy employees occupational illness- and determined the following:

•    The compensation programs have seen an expanded federal role and higher costs over time;
•    All four programs have been expanded to provide additional categories of claimants, cover more medical conditions, or provide additional benefits;
•    Some programs have been extended longer than planned;
•    There have been far more claims than estimated for each program;
•    There have been significant delays in completing claims for victims; and
•    It took at least 2 years for all four programs to become fully operational.

Both the release in numbers from Mesothelioma.com and the GAO put the potential costs needed to cover the trust fund at over $550 Billion. For the full results of our findings and for a review of the GAO report you can visit http://www.mesothelioma.com.

# # #

Press Contact: Steve Rinaldi
Company Name: IIMSNET.COM
Email: email protected from spam bots
Phone: 8004113359
Website: http://www.mesothelioma.com

Medicare Part D Controversy Causing Panic For Seniors and Family

 

Confusion Surrounding The Medicare Part D Controversy is Reaching Panic Level For Seniors and Family Members Alike

There is a lot of confusion right now concerning the Medicare Part D issue. Pressure is mounting because seniors feel they are being forced or intimidated into making a decision with Medicare Part D. The threat of penalties for not joining in time is cause for concern, and the deadline is May 15th.

(PRWEB) January 12, 2006 -- Seniors are panicky, confused and angry at the way Medicare part d is being handled. There are gapping holes in the plan when it is examined closely and most people will not be able to take advantage of the ideal savings because that ideal savings is based on a specific annual expense.

Here are some facts that may help answer the concerns and make the issue a little clearer.

The Government is enforcing Medicare Part D. Proof of this is evident if considering the penalties individuals will incur by not joining Medicare Part D by May15th. The accumulative 1% penalty (per month) can become expensive over time and looks counter productive. It seems more likely the Government agenda is geared towards herding the public into a central plan and closing the doors for international prescription imports.

Medicare Part D is great if individual retail expenses are exactly $2250 each year. The further away annual costs are from that perfect amount, the less effective the plan is.

Medicare Part D is deceptive because it is presented as a 75% savings when in reality the savings are at best 60% when the perfect amount of $2250 is spent.

Medications that are not insured obviously reduce the savings. If you spend exactly $2250 retail on insured medications then your savings will be significant, probably between 50% and 60%. So who will hit that perfect amount?

Here are some scenarios to consider: (Based on $250 deductible and monthly premiums of $35)

* Spend $1200 on insured medications - Savings will be about 16%

* Spend $3000 on insured medications - Savings will be about 36%

* Spend $4000 on insured medications - Savings will be about 27%

The Perfect Situation:

* Spend $2250 on insured medications - Savings will be 52%

Anyone who is spending more than $2250 on prescriptions each year will be unhappy paying full retail after spending beyond the $2250 mark, and possibly angry when they realize the monthly premiums are still due.

Spokesman for Professional Services Canada Darwin Corby, has this advice:

"Sit down and calculate all your prescription expenses at full retail by phoning a local Pharmacy. Get familiar with your Medicare Part D costs. Add the $250 deductible and monthly premiums together with the %25 not covered in the first $2250. Then add the full retail you will be paying in the doughnut hole on top of your costs. (The doughnut hole is the gap between $2250 and $5100)

Subtract the deductible, monthly premiums, doughnut hole expenses and 25% from the savings to find your approximate savings for the year. You also need to understand that reaching the ideal savings is highly unlikely."

A simple webpage chart is provided to help understand Medicare Part D on this page http://www.medicareaide.com/supplement.html

Recommendations:

Use a Canadian Prescription service to help avoid the Doughnut hole if expenses are high. Join a low cost Medicare Part D plan to avoid the penalties if expenses are low. Enquire about Canadian prescription prices to maximize savings

Take full advantage of Medicare Part D
Use a Canadian Pharmacy together with / or in place of Medicare part D
Call for more information
1-800-946-4820
http://www.medicareaide.com

Professional Services Canada
Contact: Dwain Berlin
1-800-946-4820
#1 Flynn Court
Port Moody B.C.
V3H4W1
www.medicareaide.com

# # #

Press Contact: Dwain Berlin
Company Name: AUTOMATIC MARKETING
Email: email protected from spam bots
Phone: 1-800-946-4820
Website: http://www.medicareaide.com

FLAVORx Develops Products For Celiac Disease Patients

 

A Company That Cares - FLAVORx Develops Products to Accommodate Needs of Celiac Disease Patients

In response to growing demand from consumers for a gluten-free and casein-free line of FLAVORx Medicinal Flavorings, President Kenny Kramm has re-vamped the products to diminish the possibilities of allergy or adverse reactions due to diet limitations. Nearly all of the 42 flavors have been modified to cater to the needs of patients who cannot consume wheat, barley, rye, oats and dairy products.

Bethesda, MD (PRWEB) January 10, 2006 -- FLAVORx, Inc., the industry standard for the flavoring of prescription and OTC drugs, now offers medicinal flavorings safe for patients suffering from Celiac Disease, gluten intolerance or wheat allergies. Additionally, FLAVORx flavorings are now also casein-free and thus friendly to consumers who face troubles digesting dairy products. In a response to consumer requests for gluten and casein-free products, the company has taken it upon itself to re-vamp its formulations to make them safe and available to consumers of all needs.

Having received calls from many parents and pharmacists regarding the gluten and casein content in FLAVORx flavorings, Kenny Kramm, President and CEO of FLAVORx, began to realize that this was a limiting factor to many children. Thus began the modification process for the existing FLAVORx product line to address the dietary limitations that consumers with Celiac Disease face. According to Kramm, “Disease, allergy or intolerance shouldn’t prevent a child from being able to have their medication taste palatable. The limitations that these children (also teens, adults and the elderly) have to face on a day to day basis are already more than most could endure, adding bad-tasting medicine to that list is adding insult to injury.” With gluten and casein-free flavors, patients can rest-assured that they will still receive the maximum benefit from their medications, without having to worry that the addition of a flavoring could cause further complication because of a specific allergy or disease.

Working with all 42 flavors, Kramm had the formulations tested for safety and efficacy, to ensure they would still be appetizing and successful to use in medications. By making these modifications, 41 of the 42 flavors are now completely safe for consumers with a chronic reaction to gluten and/or dairy products, and also better for those consumers who may be unaware of allergic conditions. This vastly reduces any incidence of complication with allergy or adverse reaction when taking a FLAVORx medication. The one flavor that is still being modified is Strawberry Cream, which contains a very small amount of casein, a milk protein; however FLAVORx researchers are currently working to alter this component while maintaining the taste characteristics and medication covering properties.

Celiac Disease is the result of an adverse reaction to glutens that causes destruction of villi in the small intestine and results in inadequate nutrient absorption. Patients with Celiac Disease are typically unable to consume gluten products containing wheat, rye, barley and oats including common items like breads, pasta, cookies and even alcoholic beverages like beer. Celiac Disease affects 1 in 133 Americans, and there is no prescriptive cure for Celiacs, except to maintain a gluten-free diet. Doing so allows for immediate repair of villi in the small intestine, and likewise regression back to a diet containing gluten can be immediately detrimental. Therefore, even a small amount of gluten, like that in a few drops of flavoring, could cause a negative reaction. When asked why he took such great lengths to ensure that the flavorings were absolutely without gluten or casein, Kramm simply stated, “When it comes to medicine, you just can’t be too careful and everybody’s health circumstances must be taken into consideration.”    

Symptoms of Celiac Disease include both intestinal and non-intestinal disorders including abdominal pain, general swelling, hair loss and malnutrition, as well as additional complications like lactose intolerance. Similarly, allergies and intolerance to gluten and casein can lead to such reactions as GI symptoms (gas, bloating) and respiratory problems.

FLAVORx’s development of flavors that are gluten and casein-free exemplifies the company’s dedication to consumer needs, so patients can be confident that flavoring their medications will not cause adverse reactions to their medications.

For more information, please visit www.flavorx.com or contact Teresa Chen at 800.884.5771, extension 234.

###

Press Contact: Teresa Chen
Company Name: FLAVORX, INC.
Email: email protected from spam bots
Phone: 240.223.0953
Website: www.flavorx.com

New Electronic Medical Records White Paper Published

 

White Paper on Electronic Medical Records Published

2K Electronic Medical Records publishes white paper on the effects of implementing Electronic Medical Records in your practice.

REDONDO BEACH, Calif. (PRWEB) January 10, 2006 -- 2K Electronic Medical Records, located in Redondo Beach, California has published a white paper entitled “Electronic Medical Records and Your Practice”.

The white paper takes an in-depth look at electronic medical records (EMR), the effects implementation can have on your practice, questions practioner’s and office personnel should ask before purchasing EMR software among other things.

2K Electronic Medical Records is a leading provider of electronic medical software for physicians and medical billing services.

Tammy Harrison, President of 2K Electronic Medical Records said, “Looking back at 2005 with President Bush’s request to have all medical records be electronic within the next 10 years, the national disasters -- like hurricane Katrina our country has experienced, we felt examining the EMR process would help practioner’s and medical billing specialists make an informed decision that is right for them.”

Ms. Harrison said, “Many practices begin to re-evaluate their business processes when they implement EMR software. Existing office procedures, patient safety and satisfaction, as well as cost effectiveness are all important factors.”

Here are some questions she advises those evaluating EMR ask before purchasing software:

1.    What goals do you expect to achieve?
2.    What basic features does your practice need?
3.    How will you enter old data into the system?
4.    What is your budget?
5.    Who in the office will assist with implementation?

2K Electronic Medical Records specializes in helping medical establishments evaluate the needs of physicians and medical billing services and develop tailored medical billing software options and solutions.

You can receive a copy of the free white paper at http://www.2kmedicalrecords.com/electronic_medical_records_white_paper.html

###

Press Contact: Kelly Robbins
Company Name: KELLY ROBBINS LLC
Email: email protected from spam bots
Phone: 310-937-8924
Website: www.2kmedicalrecords.com

Effective Pain Relief Without Medications: "Acupuncture Without Needles"

 

Effective Pain Relief Without Medications: Stanford Engineer Introduces Impressive New “Acupuncture Without Needles”

Gary Craig (Stanford ’62) has discovered a clear link between our bodily pains and our negative emotions. Used properly, EFT (Emotional Freedom Techniques) simultaneously removes or reduces emotional and physical pains in about 80% of the cases. The basics are available free on his website.

San Francisco, CA (PRWEB) January 9, 2006 -- A growing number of physicians are “tossing the meds” for some of their pain-ridden clients. Because of the dangers of many medications, a new “Acupuncture Without Needles” procedure is being substituted, often with astonishing results.

EFT (Emotional Freedom Techniques) is a dual-purpose method introduced by Stanford Engineer Gary Craig. After thousands of clinical uses it has proven effective 80% of the time and simultaneously removes or reduces both emotional and physical pain. The process involves stimulating established acupuncture meridian points by tapping on them with the fingertips. No needles are necessary.

As Eric Robins, MD states, "Someday the medical profession will wake up and realize that unresolved emotional issues are the main cause of 85% of all illnesses. When they do, EFT will be one of their primary healing tools...as it is for me."

EFT makes clear the link between our physical pains and our negative emotions. Once anger, stress, anxiety and fear abate with EFT, the corresponding pains usually subside. Sometimes the results are astonishing. Examples: Migraine headaches vanish on the spot, never to appear again. Frozen shoulders loosen and regain normal mobility. A gout sufferer goes dancing without pain.

As EFT user Bill Edens states, “We are very excited about this EFT program. My wife got rid of her back pain and too frequent headaches she has had for years. I no longer have acid reflux and no longer have to take a prescription drug for it.”

Hundreds more cases fill the EFT website. The basics can be learned and applied by anyone and are available free in the downloadable 79 page EFT Manual. See http://www.emofree.com/downloadeftmanual.htm?ref=prw . The finer points of EFT are available on low cost DVD sets and purchasers are encouraged to make up to 100 copies to give (not sell) to others.

For additional information, or for a complete press kit, contact:

Gary Craig
Emotional Freedom Techniques
707-785-2848
http://www.emofree.com

# # #

Press Contact: Gary Craig
Company Name: EFT
Email: email protected from spam bots
Phone: 707-785-2848
Website: http://www.emofree.com

Arcadian Health Plan Selects Dynamic Healthcare Systems to Meet Medicare Challenges

 

Arcadian Health Plan Selects Dynamic Healthcare Systems to Meet Medicare Challenges

Dynamic Healthcare Systems, a provider of innovative solutions for Medicare-focused health plans, today announced that Arcadian Health Plan, Inc., a provider of Medicare Advantage health plans, purchased two major components of Dynamic’s Voyager Medicare Suite.

IRVINE, CA (PRWEB) January 9, 2006 -- Dynamic Healthcare Systems, a provider of innovative solutions for Medicare-focused health plans, today announced that Arcadian Health Plan, Inc., a provider of Medicare Advantage health plans, purchased two major components of Dynamic’s Voyager Medicare Suite.

Part of Dynamic’s powerful Voyager software suite, the two modules — RAPS Management and HCC Analytics — will provide Arcadian with a critical advantage toward meeting current challenges in managing explosive Medicare populations, helping the company maximize revenues and profitability by streamlining the critical risk adjustment phase of the reimbursement process.

“After an in-depth review of several systems,” says David Lontok, President of Arcadian’s Management Services Organization, “Dynamic was selected for its flexibility in managing our data, in-depth analytics, reporting capabilities, HIPAA compliance and intuitive nature of its interface. Additionally, Dynamic fields an experienced team with a deep understanding of crucial technologies, and how to solve problems in the Medicare space. We’re very optimistic about 2006.”

The RAPS Management module should fulfill that role amply by helping Arcadian automate the way they accept, manage and exchange RAPS encounter data in conjunction with The Centers for Medicare & Medicaid Services, or CMS. The HCC Analytics solution analyses and enriches that information by applying complex algorithms to identify suspected missing or mis-coded diagnostic ICD9 codes and using secondary data like prescriptions, lab results and authorizations.

“We are very pleased that Arcadian Health Plan selected Dynamic to address their challenges of managing and analyzing risk adjusted data and reimbursements. With CMS implementing the risk adjustment payment model at 100% in 2007, plans, MSOs and providers must really focus on the way they handle encounter data today,” says Ken Stockman, Dynamic’s founder and CEO. “Their success directly depends on the quality of that information, with complete, accurate coding and reporting being key to full reimbursement. Our Voyager solution was specifically designed to help plans and MSOs address these challenges.”

About Arcadian Health Plan, Inc.
Arcadian Health Plan (AHP) is a Centers for Medicare & Medicaid Services-licensed Medicare Advantage health plan. Through state or locally-branded health plans, AHP is focused on offering value-oriented Medicare health plan options to Medicare beneficiaries who reside in small to medium-sized communities that currently do not have affordable Medicare replacement plan options available.

About Dynamic Healthcare Systems
Dynamic Healthcare Systems, Inc. was founded on delivering comprehensive solutions for Medicare Advantage health plans and MSOs striving to succeed amid new and evolving regulatory requirements. Headquartered in Irvine, California, the company brings world-class innovations to middle market companies serving the Medicare population. Dynamic Healthcare Systems can be reached at (949) 975-877. www.dynamichealthsys.com.

###

Press Contact: Jay Baker
Company Name: DYNAMIC HEALTHCARE SYSTEMS INC.
Email: email protected from spam bots
Phone: 949-975-1877
Website:

TransTech Pharma and Boehringer Ingelheim Initiate Drug Discovery Collaboration

======================================================
Drug Discovery Online Newsletter - http://www.drugdiscoveryonline.com
Friday, January 06, 2006
======================================================

-------------------------------------
TOP NEWS STORIES
-------------------------------------

1) TransTech Pharma and Boehringer Ingelheim Initiate $54 Million Drug Discovery Collaboration
2) Perlegen Forms Collaboration With Genentech in Cancer Genetics
3) Pfizer Invests $50 Million In Perlegen Sciences
4) Quintiles Book Shows Path To High-Performance Phase IIIB-IV Research
5) Xenogen Announces Extension of Global Licensing Agreement
6) Vaccine For Chronic Myeloid Leukemia Active In Patients With Persistent Disease
7) The Personalized Medicine Market Aims to Match the Most Appropriate Drug to the Right Person
8) Cetek Raises $10 Million To Advance Drug Discovery And Development
---------------------------------------

1) TransTech Pharma and Boehringer Ingelheim Initiate $54 Million Drug Discovery Collaboration

TransTech Pharma, Inc. recently announced a worldwide research and license collaboration with Boehringer Ingelheim GmbH using TransTech's proprietary TTP Translational Technology(R)...
http://www.drugdiscoveryonline.com/

2) Perlegen Forms Collaboration With Genentech in Cancer Genetics

Perlegen Sciences, Inc. announced today that it has begun a collaboration with Genentech, Inc. to study the genetics of cancer...
http://www.drugdiscoveryonline.com/

3) Pfizer Invests $50 Million In Perlegen Sciences

Perlegen Sciences, Inc. announced recently that Pfizer Inc has made a $50 million equity investment in Perlegen, taking a twelve percent position in the private biotechnology company...
http://www.drugdiscoveryonline.com/

4) Quintiles Book Shows Path To High-Performance Phase IIIB-IV Research

Patients, physicians, payers and politicians are calling for more information on the risks and benefits of prescription drugs. At the same time, some organizations are questioning the value of direct-to-consumer advertising...
http://www.drugdiscoveryonline.com/

5) Xenogen Announces Extension of Global Licensing Agreement

Xenogen Corporation announced recently an extension of its licensing agreement with Novartis for up to two more years...
http://www.drugdiscoveryonline.com/

6) Vaccine For Chronic Myeloid Leukemia Active In Patients With Persistent Disease

Breakthrough Therapeutics, a privately owned biotechnology company, recently announced the presentation of positive interim data for a novel vaccine known as VAX100 for patients with persistent chronic myeloid leukemia (CML) while on imatinib mesylate (Gleevec(R); Novartis)...
http://www.drugdiscoveryonline.com/

7) The Personalized Medicine Market Aims to Match the Most Appropriate Drug to the Right Person

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype...
http://www.drugdiscoveryonline.com/

8) Cetek Raises $10 Million To Advance Drug Discovery And Development

Cetek Corporation announced it has raised $10 million to advance its proprietary drug discovery platform and its emerging pipeline of compounds to treat cancer and infectious diseases...
http://www.drugdiscoveryonline.com/


-------------------------------------
FEATURED PRODUCTS
-------------------------------------

1) Analytical SFC with fractionation
2) Chromatography
3) LyoStar IIT Research and Development Tray Dryer
4) Nano Flow Sensor
5) Vetter Development Service
---------------------------------------

1) Analytical SFC with fractionation

Thar's analytical SFC offers faster separations (4 times faster than HPLC) due to the low viscosity of the primary mobile phase (CO2). Additionally, the analytical SFC utilizes Thar's new high pressure fluid pumping module that archieves flow rates of 0.1 g/min to 10 g/min at pressures up to 400 bar...
http://www.drugdiscoveryonline.com/

2) Chromatography

Disposable Membrane Chromatography units are designed for the rapid selection of appropriate chemistry and method development. The Mustang membrane chromatography starter kit includes both strong anion and cation exchange membrane chromatography Acrodisc® units, as well as specific endotoxin removal Acrodisc units...
http://www.drugdiscoveryonline.com/

3) LyoStar II(TM) Research and Development Tray Dryer

LyoStar II(TM) Research and Development Tray Dryer for process development for scale-up, Product processing for stability studies, Formulation work...
http://www.drugdiscoveryonline.com/

4) Nano Flow Sensor

Developed by Upchurch Scientific® in cooperation with Honeywell, this noninvasive Nano Flow Sensor reports flow rate in the nanoliter through low microliter-per-minute range...
http://www.drugdiscoveryonline.com/

5) Vetter Development Service

As specialists in the handling of highly sensitive active substances, we can guarantee that your liquid or freezedried active substances will be produced quickly, efficiently and carefully...
http://www.drugdiscoveryonline.com/

-------------------------------------
FEATURED DOWNLOAD
-------------------------------------

Datasheet: Pallsep(TM) Vibrating Membrane Filtration Technology

In the Pallsep system, controlled horizontal oscillation moves the membrane
elements through the feed fluid over 50 times per second...
http://www.drugdiscoveryonline.com/

-------------------------------------
CONSULTING SERVICES
-------------------------------------

ProSavvy brings clients with projects together with consultants who have the right expertise. We also provide consultants the ability to access project opportunities. Visit http://www.drugdiscoveryonline.com/ and post your project today!


-------------------------------------
TRAINING RESOURCES
-------------------------------------

Thinking About Continuing Your Education?
Let us help you find the right school for you. Whether you would like to get an Associate's Degree, Bachelor's Degree or Master's Degree we can help you pinpoint which schools to choose from.
http://www.drugdiscoveryonline.com/


-------------------------------------
TRADE PUBLICATIONS
-------------------------------------

Browse from the extensive list of complimentary trade publications. Visit http://www.drugdiscoveryonline.com/ for more information.

-------------------------------------
NEWSLETTER SUBSCRIPTION
-------------------------------------

If you do not currently receive the Drug Discovery Online newsletter and wish to become a subscriber, click here:
http://www.drugdiscoveryonline.com/

-------------------------------------
ADVERTISE ONLINE
-------------------------------------

If you are interested in advertising with Drug Discovery Online, and would like more information, click here:
http://www.drugdiscoveryonline.com/

==========================================================
(c)Copyright 2005 VertMarkets LLC, 5 Walnut Grove Drive, Suite 320, Horsham, PA 19044-2245. All rights reserved.

Survivors of Radon-Induced Lung Cancer Speak Out

Survivors of Radon-Induced Lung Cancer Speak Out

Elizabeth Hoffmann of Milwaukee, Wisconsin is a survivor of radon induced lung cancer. Although she has never smoked, her 15-year exposure to dangerous levels of radon in her home resulted in doctors having to remove the cancerous lower lobe of her left lung prior to her 38th birthday.

(PRWEB) January 4, 2006 -- Elizabeth Hoffmann of Milwaukee, Wisconsin is a survivor of radon induced lung cancer. Although, she has never smoked, her 15-year exposure to dangerous levels of radon in her home resulted in doctors having to remove the cancerous lower lobe of her left lung prior to her 38th birthday.

More than a year ago, Liz announced the creation of a new website for Cancer Survivors Against Radon www.cansar.org. Its purpose is to put a face on radon by empowering sufferers of radon-induced lung cancer (and their families) with a unified voice and to prevent LC victims from remaining clueless.

Since few oncologists provide a potential explanation for the cause, most non-smokers diagnosed with lung cancer never make the association with radon exposure. Liz would remain clueless herself, if it had not been for the determination of her family to find out why. Her cousin mentioned radon as a possibility to her father, who tested Liz’s house for radon upon her return from the hospital. The results were over twice EPA’s Recommended Radon Action Level.

The CANSAR Registry enables non-smoking lung cancer patients and their families to register with the organization and order a free radon test kit for their home. Survivors and their families can choose to join others who are committed to warning the public about the danger of indoor radon. Approximately 50% of the people diagnosed with lung cancer have never smoked or are former smokers, including a 17% occurrence in never smokers.

“While it is obviously too late to preclude our cancer, our stories may convince others to prevent deadly radon exposure by testing and fixing,” says Liz. “We can also shape public policy by convincing lawmakers and government agencies to treat the radon issue and lung cancer with the seriousness it deserves. But it’s difficult to put together an advocacy group when 85% of the victims die within five years of being diagnosed. They’re just struggling to survive”.

Lucky for Liz, they caught her cancer early. The National Academy of Sciences (NAS) and EPA blame radon exposure for the deaths of 21,000 Americans annually. But, their deaths, like Liz’s cancer, could have been prevented. A simple radon test at the time she bought her home in 1988 would have alerted her and her husband to fix their house before moving in.

In April of this year Dennie Edwards, a real estate agent for Realty-One in Elyria, Ohio went to the doctor with a very bad cold. After the doctor performed a chest x-ray to check for pneumonia, he was shocked to find a 4.5-centimeter mass in his left lung. Like Liz, Dennie had never smoked. But, even though he had been a real estate agent for 31 years, he had never bothered to test his house for radon.

“To protect my liability, I always informed my clients that radon testing prior to purchase was an option, but truthfully, I really didn't care if they tested or not,” says Dennie. “Now I had to wonder whether my lung cancer had been caused by radon exposure.”

While the doctor scheduled his surgery, Dennie scheduled a radon test. The result was 10 pCi/l, (two and a half times the EPA's recommended Action Level). He had lived in the home for 12 years. He immediately called a contractor to have a mitigation system installed. Two days later he had surgery.

“I thought I was surely going to die,” says Dennie. “When I woke up choking with tubes in my throat, panic set in.” They had removed his entire left lung.

“I'm getting better. I can walk up to a mile,” he continues. “ But, I can no longer dance, lift things, or exert myself. My clients now get a very personal testimonial about the importance of testing for radon.”

Dr. Lane Mathis Price, Medical Director and Oncologist at the Decatur (AL) General Oncology Center has seen her share of lung cancer victims.

“People come into my office and say Doc Price I just don’t understand it. How can this happen to me? I don’t smoke. Nobody ever smokes around me. How can I have lung cancer?"

"Convincing the public that radon is dangerous is made more difficult because the nation’s leading housing authority, (the U.S. Department of Housing and Urban Development) refuses to take action to prevent radon exposure in our homes,” says Price. “ HUD requires a termite letter to qualify for a mortgage, yet to my knowledge a termite never killed anybody. Why are they not requiring a radon test?”

“Never underestimate the importance of prevention in all aspects of your life,” warns Dr. Michael Dick, Director of Internal Medicine at Decatur Adult Medicine. “If you’re a lung cancer victim aware of all the ways it is impacting you and your family -- you’d be kicking yourself if you knew something a simple as a radon detection device would have allowed you to prevent this from occurring.”

"There also needs to be a much greater effort to find a cure," explains Liz. "Even though lung cancer kills more Americans than breast, prostate and colorectal cancers combined, very little money is spent on lung cancer research."

In 2003, approximately $1,740 was spent on research per lung cancer death, compared with:$13,649 per breast cancer death, $10,560 per prostate cancer death and $4,581 per colorectal cancer death.

# # #

Press Contact: Dallas Jones
Company Name: AMERICAN RADON POLICY COALITION
Email: email protected from spam bots
Phone: 678-895-1639
Website: www.cansar.org